Kevin
Vangehr

Associate
MLaw | Attorney at law

Kevin Vangehr

About

Kevin Vangehr practices in the areas of M&A, venture capital and private equity, restructuring and bankruptcy, and general corporate and trade law.

“An important cornerstone of my philosophy on life is the following excerpt from a well-known speech: ‘Stay hungry, stay foolish.’ I live by this motto: I’m always looking to improve – whether in my work as a lawyer, while rock climbing or simply as a person. It takes constant drive and discipline, and of course that ‘hunger‘. At the same time, it is important to me to maintain a sense of foolishness and curiosity. You shouldn’t take yourself too seriously – you should also allow yourself to be a bit crazy and dare to do extraordinary things.”

Kevin Vangehr speaks German and English.

Kevin Vangehr
05.07.2024

Deal: Wenger Vieli advised the shareholders of moneyland on the sale to SMG Swiss Marketplace Group AG

18.06.2024

Deal: Wenger Vieli acted as Swiss legal counsel to Inner Mongolia Mengtai Group on the acquisition of Alu Menziken Extrusion

22.03.2024

Deal: Wenger Vieli acted as Swiss legal advisor to NLS Pharmaceutics

20.12.2023

Deal: Wenger Vieli advised the sellers of Swiss Dental Solutions Group on the sale of its majority stake shareholding

20.09.2023

Deal: Wenger Vieli advised sell-side in the sale transaction of EXALOS to indie Semiconductor

07.09.2023

Deal: Wenger Vieli advised Axa Venture Partners on its investment in Deskbird's Series A financing round

31.07.2023

Deal: IK Partners sells Klingel Medical Group to Elos Medtech AB

07.07.2023

Deal: Wenger Vieli advised the Sellers of Seervision on the sale to QSC LLC

13.12.2022

Deal: Wenger Vieli acted as Swiss legal advisor to NLS Pharmaceutics

15.11.2022

Wenger Vieli advised the lead investor Redalpine Opportunity Fund on the closing of Carvolution's Series D Financing Round

07.11.2022

Wenger Vieli advises LatticeFlow on closing of its Series A financing round of USD 12m

07.10.2022

Deal: Wenger Vieli advised NLS Pharmaceutics on a Private Placement Transaction

28.09.2022

DEAL: Wenger Vieli advised the share­holders of MENU Technologies in a cross-border transaction

27.04.2022

Deal: NLS Pharmaceutics closes of a USD 4.4m registered direct offering

26.04.2022

Deal: Fu-Gen secures EUR 320m funding deal

17.12.2021

Deal: Klingel-medical metal Acquires Ruetschi Group

16.11.2021

Deal: Investment in Home Instead Group by Unigestion SA

13.08.2021

Deal: Advisor to Atlas Antibodies

Since 2024 Currently in the LLM
Since 2021 Lawyer at Wenger Vieli Ltd.
2021 Admission to the Bar
2018-2020 Junior Lawyer at Wenger Vieli Ltd.
2018 Legal Employee at Bertisch Kreutzmann Rechtsanwälte
2018 University of Zurich (MLaw)
2018 University of Lund (exchange semester)
2014-2017 Legal Employee at Bertisch Kreutzmann Rechtsanwälte
2017 University of Zurich (BLaw)
  • Swiss Bar Association (SAV)
  • Zurich Bar Association (ZAV)